Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)
Brazil flag Brazil · Delayed Price · Currency is BRL
1.070
-0.040 (-3.60%)
Jul 8, 2026, 4:40 PM GMT-3

BVMF:ONCO3 Statistics

Total Valuation

BVMF:ONCO3 has a market cap or net worth of BRL 1.20 billion. The enterprise value is 5.01 billion.

Market Cap1.20B
Enterprise Value 5.01B

Important Dates

The next confirmed earnings date is Thursday, August 6, 2026.

Earnings Date Aug 6, 2026
Ex-Dividend Date n/a

Share Statistics

BVMF:ONCO3 has 1.12 billion shares outstanding. The number of shares has increased by 49.00% in one year.

Current Share Class 1.12B
Shares Outstanding 1.12B
Shares Change (YoY) +49.00%
Shares Change (QoQ) -42.02%
Owned by Insiders (%) 5.08%
Owned by Institutions (%) 50.25%
Float 447.22M

Valuation Ratios

PE Ratio n/a
Forward PE 35.31
PS Ratio 0.22
PB Ratio 1.93
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.93
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.46, with a Debt / Equity ratio of 6.18.

Current Ratio 0.46
Quick Ratio 0.34
Debt / Equity 6.18
Debt / EBITDA n/a
Debt / FCF -8.95
Interest Coverage -2.71

Financial Efficiency

Return on equity (ROE) is -205.90% and return on invested capital (ROIC) is -38.58%.

Return on Equity (ROE) -205.90%
Return on Assets (ROA) -12.04%
Return on Invested Capital (ROIC) -38.58%
Return on Capital Employed (ROCE) -125.12%
Weighted Average Cost of Capital (WACC) 11.95%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.62
Inventory Turnover 23.48

Taxes

In the past 12 months, BVMF:ONCO3 has paid 471.06 million in taxes.

Income Tax 471.06M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -79.70% in the last 52 weeks. The beta is 0.89, so BVMF:ONCO3's price volatility has been lower than the market average.

Beta (5Y) 0.89
52-Week Price Change -79.70%
50-Day Moving Average 1.30
200-Day Moving Average 2.01
Relative Strength Index (RSI) 41.34
Average Volume (20 Days) 7,759,170

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BVMF:ONCO3 had revenue of BRL 5.41 billion and -3.84 billion in losses. Loss per share was -4.10.

Revenue5.41B
Gross Profit 1.57B
Operating Income -1.69B
Pretax Income -3.51B
Net Income -3.84B
EBITDA -1.52B
EBIT -1.69B
Loss Per Share -4.10
Full Income Statement

Balance Sheet

The company has 112.29 million in cash and 3.84 billion in debt, with a net cash position of -3.73 billion or -3.33 per share.

Cash & Cash Equivalents 112.29M
Total Debt 3.84B
Net Cash -3.73B
Net Cash Per Share -3.33
Equity (Book Value) 621.00M
Book Value Per Share 0.48
Working Capital -2.88B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -260.80 million and capital expenditures -168.12 million, giving a free cash flow of -428.92 million.

Operating Cash Flow -260.80M
Capital Expenditures -168.12M
Depreciation & Amortization 169.26M
Net Borrowing -363.05M
Free Cash Flow -428.92M
FCF Per Share -0.38
Full Cash Flow Statement

Margins

Gross margin is 29.10%, with operating and profit margins of -31.23% and -71.05%.

Gross Margin 29.10%
Operating Margin -31.23%
Pretax Margin -64.86%
Profit Margin -71.05%
EBITDA Margin -28.10%
EBIT Margin -31.23%
FCF Margin n/a

Dividends & Yields

BVMF:ONCO3 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -49.00%
Shareholder Yield -49.00%
Earnings Yield -321.07%
FCF Yield -35.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Analyst Forecast

The average price target for BVMF:ONCO3 is 2.40, which is 124.30% higher than the current price. The consensus rating is "Sell".

Price Target 2.40
Price Target Difference 124.30%
Analyst Consensus Sell
Analyst Count 7
Revenue Growth Forecast (3Y) 2.43%
EPS Growth Forecast (3Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BVMF:ONCO3 has an Altman Z-Score of -1.25 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.25
Piotroski F-Score 2